author-photo

Vincenzo Colangeli

University of Bologna

76

Papers

1917

Citations

Citation Trend

Filter By

Papers (52) Sort By

Journal Conference Others

NO SIGNIFICANT INCREASE IN BODY FAT MASS IN NAIVE HIV-INFECTED PATIENTS STARTING RALTEGRAVIR PLUS TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE.

2020 AIDS Research and Human Retroviruses
Show All
- Source
- Cite
- Save
Citations (0)
Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy.

2020 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (1)
NO SIGNIFICANT CHANGES IN WEIGHT AND BODY FAT MASS IN SUPPRESSED HIV-INFECTED PATIENTS SWITCHED TO DUAL COMBINATION LAMIVUDINE PLUS DOLUTEGRAVIR OR RALTEGRAVIR.

2020 AIDS Research and Human Retroviruses
Show All
- Source
- Cite
- Save
Citations (3)
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy.

2020 Infection
Show All
- Source
- Cite
- Save
Citations (23)
COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION

2020 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (5)
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy

2019 Clinical and Experimental Nephrology
Show All
- Source
- Cite
- Save
Citations (5)
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients

2019 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (13)
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease

2019 Infectious diseases
Show All
- Source
- Cite
- Save
Citations (11)
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

2019 Infection
Show All
- Source
- Cite
- Save
Citations (8)
The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

2019 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (3)